Alvotech (NASDAQ:ALVOW – Get Free Report) saw a significant decrease in short interest during the month of December. As of December 15th, there was short interest totaling 946 shares, a decrease of 98.6% from the November 30th total of 68,749 shares. Based on an average daily volume of 10,749 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 10,749 shares, the days-to-cover ratio is currently 0.1 days.
Alvotech Price Performance
NASDAQ:ALVOW opened at $0.85 on Friday. The stock has a 50 day simple moving average of $0.96 and a 200 day simple moving average of $1.32. Alvotech has a 1-year low of $0.57 and a 1-year high of $4.99.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Recommended Stories
- Five stocks we like better than Alvotech
- Put $1,000 into this stock by Jan 1 [Not NVDA]
- Turn your “dead money” into $306+ monthly (starting this month)
- Washington prepares for war
- Strange Crystal Metal Outperforms Silicon Up to 100X
- 33,000% boom from weird new “AI Fuel?”
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
